(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||
The |
Item 2.02 | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits. |
99.1 | |||||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
PERFORMANT FINANCIAL CORPORATION | ||||||||
By: | /s/ Ian Johnston | |||||||
Ian Johnston | ||||||||
Chief Accounting Officer |
September 30, 2022 | December 31, 2021 | ||||||||||
(Unaudited) | |||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 25,591 | $ | 17,347 | |||||||
Restricted cash | 81 | 2,203 | |||||||||
Trade accounts receivable, net of allowance for doubtful accounts of $0 and $0, respectively | 15,850 | 20,808 | |||||||||
Contract assets | 9,735 | 8,113 | |||||||||
Prepaid expenses and other current assets | 2,395 | 3,077 | |||||||||
Income tax receivable | 3,211 | 3,159 | |||||||||
Total current assets | 56,863 | 54,707 | |||||||||
Property, equipment, and leasehold improvements, net | 10,681 | 15,708 | |||||||||
Goodwill | 47,372 | 47,372 | |||||||||
Right-of-use assets | 2,394 | 3,235 | |||||||||
Other assets | 970 | 963 | |||||||||
Total assets | $ | 118,280 | $ | 121,985 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Current maturities of notes payable, net of unamortized debt issuance costs of $16 and $11, respectively | $ | 859 | $ | 489 | |||||||
Accrued salaries and benefits | 6,532 | 8,476 | |||||||||
Accounts payable | 785 | 1,124 | |||||||||
Other current liabilities | 2,304 | 3,732 | |||||||||
Contract liabilities | 531 | 634 | |||||||||
Estimated liability for appeals and disputes | 1,148 | 1,190 | |||||||||
Lease liabilities | 1,303 | 1,862 | |||||||||
Total current liabilities | 13,462 | 17,507 | |||||||||
Notes payable, net of current portion and unamortized debt issuance costs of $341 and $416, respectively | 18,409 | 19,084 | |||||||||
Lease liabilities | 1,365 | 1,803 | |||||||||
Other liabilities | 1,148 | 1,168 | |||||||||
Total liabilities | 34,384 | 39,562 | |||||||||
Commitments and contingencies (note 3 and note 4) | |||||||||||
Stockholders’ equity: | |||||||||||
Common stock, $0.0001 par value. Authorized, 500,000 shares at September 30, 2022 and December 31, 2021 respectively; issued and outstanding 74,212 and 69,281 shares at September 30, 2022 and December 31, 2021, respectively | 7 | 7 | |||||||||
Additional paid-in capital | 141,437 | 133,662 | |||||||||
Accumulated deficit | (57,548) | (51,246) | |||||||||
Total stockholders’ equity | 83,896 | 82,423 | |||||||||
Total liabilities and stockholders’ equity | $ | 118,280 | $ | 121,985 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Revenues | $ | 27,178 | $ | 28,582 | $ | 79,942 | $ | 92,814 | ||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Salaries and benefits | 21,759 | 19,686 | 63,101 | 67,071 | ||||||||||||||||||||||
Other operating expenses | 7,733 | 8,781 | 23,945 | 29,896 | ||||||||||||||||||||||
Impairment of goodwill | — | — | — | — | ||||||||||||||||||||||
Total operating expenses | 29,492 | 28,467 | 87,046 | 96,967 | ||||||||||||||||||||||
Income (loss) from operations | (2,314) | 115 | (7,104) | (4,153) | ||||||||||||||||||||||
Gain on sale of certain recovery contracts | — | 579 | 382 | 2,428 | ||||||||||||||||||||||
Gain on sale of land and buildings | 1,120 | — | 1,120 | — | ||||||||||||||||||||||
Interest expense | (277) | (2,394) | (648) | (5,866) | ||||||||||||||||||||||
Loss before provision for income taxes | (1,471) | (1,700) | (6,250) | (7,591) | ||||||||||||||||||||||
Provision for (benefit from) income taxes | (11) | (9) | 52 | 61 | ||||||||||||||||||||||
Net loss | $ | (1,460) | $ | (1,691) | $ | (6,302) | $ | (7,652) | ||||||||||||||||||
Net loss per share | ||||||||||||||||||||||||||
Basic | $ | (0.02) | $ | (0.03) | $ | (0.09) | $ | (0.13) | ||||||||||||||||||
Diluted | $ | (0.02) | $ | (0.03) | $ | (0.09) | $ | (0.13) | ||||||||||||||||||
Weighted average shares | ||||||||||||||||||||||||||
Basic | 74,021 | 62,127 | 72,480 | 57,512 | ||||||||||||||||||||||
Diluted | 74,021 | 62,127 | 72,480 | 57,512 |
Nine Months Ended September 30, | |||||||||||
2022 | 2021 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net loss | $ | (6,302) | $ | (7,652) | |||||||
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||||||
Loss on disposal of assets and impairment of long-lived assets | 40 | 718 | |||||||||
Depreciation and amortization | 3,355 | 3,883 | |||||||||
Right-of-use assets amortization | 841 | 1,413 | |||||||||
Stock-based compensation | 2,212 | 1,963 | |||||||||
Interest expense from debt issuance costs | 71 | 2,453 | |||||||||
Gain on sale of certain recovery contracts | (382) | (2,428) | |||||||||
Gain on sale of land and buildings | (1,120) | — | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Trade accounts receivable | 4,958 | 4,270 | |||||||||
Contract assets | (1,622) | (484) | |||||||||
Prepaid expenses and other current assets | 682 | 1,245 | |||||||||
Income tax receivable | (52) | 1,305 | |||||||||
Other assets | (7) | 120 | |||||||||
Accrued salaries and benefits | (1,944) | (3,739) | |||||||||
Accounts payable | (339) | 422 | |||||||||
Contract liabilities and other current liabilities | (1,515) | (1,363) | |||||||||
Estimated liability for appeals, disputes, and refunds | (42) | 1,240 | |||||||||
Lease liabilities | (997) | (1,635) | |||||||||
Other liabilities | (19) | (445) | |||||||||
Net cash (used in) provided by operating activities | (2,182) | 1,286 | |||||||||
Cash flows from investing activities: | |||||||||||
Purchase of property, equipment, and leasehold improvements | (2,198) | (2,695) | |||||||||
Proceeds from sale of certain recovery contracts | 382 | 3,171 | |||||||||
Proceeds from sales of property, equipment, and leasehold improvements | 4,934 | — | |||||||||
Net cash provided by investing activities | 3,118 | 476 | |||||||||
Cash flows from financing activities: | |||||||||||
Repayment of notes payable | (375) | (8,438) | |||||||||
Debt issuance costs paid | (2) | (150) | |||||||||
Taxes paid related to net share settlement of stock awards | — | (633) | |||||||||
Proceeds from exercise of warrants | 5,563 | 41 | |||||||||
Proceeds from public offering, net of costs | — | 42,648 | |||||||||
Net cash provided by financing activities | 5,186 | 33,468 | |||||||||
Net increase in cash, cash equivalents and restricted cash | 6,122 | 35,230 | |||||||||
Cash, cash equivalents and restricted cash at beginning of period | 19,550 | 18,296 | |||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 25,672 | $ | 53,526 | |||||||
Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets: | |||||||||||
Cash and cash equivalents | $ | 25,591 | $ | 51,323 | |||||||
Restricted cash | 81 | 2,203 | |||||||||
Total cash, cash equivalents and restricted cash at end of period | $ | 25,672 | $ | 53,526 | |||||||
Non-cash financing activities: | |||||||||||
Recognition of earnout shares issued | $ | — | $ | 801 | |||||||
Recognition of warrants associated with notes payable | $ | — | $ | 5,237 | |||||||
Supplemental disclosures of cash flow information: | |||||||||||
Cash paid (received) for income taxes | $ | 267 | $ | (683) | |||||||
Cash paid for interest | $ | 449 | $ | 3,413 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in thousands) | (in thousands) | |||||||||||||||||||||||||
Adjusted EBITDA: | ||||||||||||||||||||||||||
Net income (loss) | $ | (1,460) | $ | (1,691) | $ | (6,302) | $ | (7,652) | ||||||||||||||||||
Provision for (benefit from) income taxes | (11) | (9) | 52 | 61 | ||||||||||||||||||||||
Interest expense (1) | 277 | 2,394 | 648 | 5,866 | ||||||||||||||||||||||
Stock-based compensation | 931 | 540 | 2,212 | 1,963 | ||||||||||||||||||||||
Depreciation and amortization | 1,095 | 843 | 3,355 | 3,883 | ||||||||||||||||||||||
Impairment of long-lived assets | — | — | — | 636 | ||||||||||||||||||||||
Severance expenses (4) | 10 | 380 | 189 | 1,876 | ||||||||||||||||||||||
Non-core operating expenses (5) | 3 | $ | 775 | 9 | 2,683 | |||||||||||||||||||||
Gain on sale of certain recovery contracts (6) | — | (579) | (382) | (2,428) | ||||||||||||||||||||||
Gain on sale of land and buildings (7) | $ | (1,120) | $ | — | $ | (1,120) | $ | — | ||||||||||||||||||
Adjusted EBITDA | $ | (275) | $ | 2,653 | $ | (1,339) | $ | 6,888 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in thousands) | (in thousands) | |||||||||||||||||||||||||
Adjusted Net Income (Loss): | ||||||||||||||||||||||||||
Net income (loss) | $ | (1,460) | $ | (1,691) | $ | (6,302) | $ | (7,652) | ||||||||||||||||||
Stock-based compensation | 931 | 540 | 2,212 | 1,963 | ||||||||||||||||||||||
Amortization of intangible assets (2) | — | 72 | — | 689 | ||||||||||||||||||||||
Amortization of debt issuance costs (3) | 23 | 1,320 | 71 | 2,453 | ||||||||||||||||||||||
Impairment of long-lived assets | — | — | — | 636 | ||||||||||||||||||||||
Severance expenses (4) | 10 | 380 | 189 | 1,876 | ||||||||||||||||||||||
Non-core operating expenses (5) | 3 | — | 9 | 2,683 | ||||||||||||||||||||||
Gain on sale of certain recovery contracts (6) | — | (579) | (382) | (2,428) | ||||||||||||||||||||||
Gain on sale of land and buildings (7) | (1,120) | — | (1,120) | — | ||||||||||||||||||||||
Tax adjustments (8) | (42) | (690) | (269) | (2,165) | ||||||||||||||||||||||
Adjusted net income (loss) | $ | (1,655) | $ | 127 | $ | (5,592) | $ | (1,945) |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in thousands) | (in thousands) | |||||||||||||||||||||||||
Adjusted Net Income (Loss) Per Diluted Share: | ||||||||||||||||||||||||||
Net income (loss) | $ | (1,460) | $ | (1,691) | $ | (6,302) | $ | (7,652) | ||||||||||||||||||
Plus: Adjustment items per reconciliation of adjusted net income (loss) | (195) | 1,818 | 710 | 5,707 | ||||||||||||||||||||||
Adjusted net income (loss) | $ | (1,655) | $ | 127 | $ | (5,592) | $ | (1,945) | ||||||||||||||||||
Adjusted net income (loss) per diluted share | $ | (0.02) | $ | — | $ | (0.08) | $ | (0.03) | ||||||||||||||||||
Diluted average shares outstanding (9) | 74,021 | 67,948 | 72,480 | 57,512 |
Nine months ended | Three months ended | Year Ended | ||||||||||||||||||||||||
September 30, 2022 | December 31, 2022 | December 31, 2021 | December 31, 2022 | |||||||||||||||||||||||
Actual | Estimate | Actual | Estimate | |||||||||||||||||||||||
Adjusted EBITDA: | ||||||||||||||||||||||||||
Net income (loss) | $ | (6,302) | $ (1,144) to (1,755) | $ | (10,288) | $ (7,446) to (8,057) | ||||||||||||||||||||
Provision for (benefit from) income taxes | $ | 52 | (302) to 198 | 62 | (250) to 250 | |||||||||||||||||||||
Interest expense (1) | $ | 648 | 102 to 602 | 11,313 | 750 to 1,250 | |||||||||||||||||||||
Stock-based compensation | $ | 2,212 | 538 to 1,038 | 2,640 | 2,750 to 3,250 | |||||||||||||||||||||
Depreciation and amortization | $ | 3,355 | 1,145 to 2,145 | 5,188 | 4,500 to 5,500 | |||||||||||||||||||||
Impairment of long-lived assets | $ | — | — | 636 | — | |||||||||||||||||||||
Severance expenses (4) | $ | 189 | 0 to 111 | 2,160 | 189 to 300 | |||||||||||||||||||||
Non-core operating expenses (5) | $ | 9 | — | 2,588 | 9 | |||||||||||||||||||||
Gain on sale of certain recovery contracts (6) | $ | (382) | — | (2,403) | (382) | |||||||||||||||||||||
Gain on sale of land and buildings (7) | $ | (1,120) | — | — | (1,120) | |||||||||||||||||||||
Adjusted EBITDA | $ | (1,339) | $ 339 to 2,339 | $ | 11,896 | $ (1,000) to 1,000 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||
March 31, 2022 | June 30, 2022 | September 30, 2022 | September 30, 2022 | |||||||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||||
Eligibility-based | $ | 14,214 | $ | 12,417 | $ | 13,142 | $ | 39,773 | ||||||||||||||||||
Claims-based | 9,150 | 9,339 | 10,377 | 28,866 | ||||||||||||||||||||||
Healthcare Total | 23,364 | 21,756 | 23,519 | 68,639 | ||||||||||||||||||||||
Recovery | 118 | 7 | 41 | 166 | ||||||||||||||||||||||
Customer Care / Outsourced Services | 3,601 | 3,918 | 3,618 | 11,137 | ||||||||||||||||||||||
Total | $ | 27,083 | $ | 25,681 | $ | 27,178 | $ | 79,942 |
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
March 31, 2021 | June 30, 2021 | September 30, 2021 | December 31, 2021 | December 31, 2021 | ||||||||||||||||||||||||||||
Eligibility-based | $ | 7,911 | $ | 11,577 | $ | 12,727 | $ | 16,061 | $ | 48,276 | ||||||||||||||||||||||
Claims-based | 5,375 | 7,025 | 7,280 | 9,498 | 29,178 | |||||||||||||||||||||||||||
Healthcare Total | 13,286 | 18,602 | 20,007 | 25,559 | 77,454 | |||||||||||||||||||||||||||
Recovery | 14,491 | 11,091 | 5,490 | 2,333 | 33,405 | |||||||||||||||||||||||||||
Customer Care / Outsourced Services | 3,613 | 3,149 | 3,085 | 3,687 | 13,534 | |||||||||||||||||||||||||||
Total | $ | 31,390 | $ | 32,842 | $ | 28,582 | $ | 31,579 | $ | 124,393 |
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
March 31, 2020 | June 30, 2020 | September 30, 2020 | December 31, 2020 | December 31, 2020 | ||||||||||||||||||||||||||||
Eligibility-based | $ | 10,949 | $ | 11,292 | $ | 13,480 | 14,126 | $ | 49,847 | |||||||||||||||||||||||
Claims-based | 6,575 | 3,301 | 4,086 | 4,739 | 18,701 | |||||||||||||||||||||||||||
Healthcare Total | 17,524 | 14,593 | 17,566 | 18,865 | 68,548 | |||||||||||||||||||||||||||
Recovery | 24,265 | 16,167 | 15,443 | 17,521 | 73,396 | |||||||||||||||||||||||||||
Customer Care / Outsourced Services | 4,099 | 3,025 | 3,219 | 3,650 | 13,993 | |||||||||||||||||||||||||||
Total | $ | 45,888 | $ | 33,785 | $ | 36,228 | $ | 40,036 | $ | 155,937 |
Cover |
Nov. 08, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Nov. 08, 2022 |
Entity Registrant Name | Performant Financial Corporation |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-35628 |
Entity Tax Identification Number | 20-0484934 |
Entity Address, Address Line One | 333 North Canyons Parkway |
Entity Address, City or Town | Livermore |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94551 |
City Area Code | (925) |
Local Phone Number | 960-4800 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Trading Symbol | PFMT |
Security Exchange Name | NASDAQ |
Title of 12(b) Security | Common Stock, par value $.0001 per share |
Entity Central Index Key | 0001550695 |
Amendment Flag | false |
5\A(BWGQ8D:DR2:(#.32E=][M]DHFR;(N)9@-/YJ%3F@8
M6CY@015W?T U$\6. #1/Q[[G6)F8KHOF
M2!$ADX*(_0>C(6LUW.GW =7I@
M]A4 .B- 1 <&9M="TR,#(R,3$P."YH=&WM7>MWVKBV_W[^"E_.O>>D
M:T6.Y;=IF[.80!@ZL6D3TASXTB5;[JX]7@]NK3W=;N5S\C#:KX>5BIO=OU.5^
MR=V8L1?"N549^QG/9T^.]6*P\0?F=)/Y440ZX:&/MZ]$XS=-)TF-GBD6;GB>
MP[1<.@W9^^R/"\#%F(OQ/CFW=
U+7J* 8MR%R
MESD%\^[091?T7V#KA@;VQWB#&&7M1WG4FH?=BNOH;S1TK#*\]A:LH75:)N7.
M'F"O1GA.B%N5YH;BEO^$N! W(6Y[BUN.O30A;D+<#A0WI1SK=M3.&E6'KA\=
M-XZ8?0J?\CA>11.U,3\!*J^K>8!O[NF7O,4O!+E-@IQCT1&"+ 2YNH*.[K\#U>[TYIXNR:IHLUAQ+G5525'WK,PON%28+JF2;N:M="6X
M5/21FYYD*"4>NSEJ8DB_^H
W6*+;+)U\S\9<4.V')H;)V"'(QAA2,8IJRX_O%^Z
M8 M'-,HKO0=3^!QL;3?.LCBJ=HA:
MEMT.4;
\PZ\^G*/XQK][=#GUV?GK$!/>JJ!C/%RN[Y:KMI7M""[K]
M%/=':<9?PGCW\-=7"",/O.REK.:BG8\.K(B "DOR7AU/O/'#;P<#!_V ^6"M
M7%[\:N=)GY,['#2]!CM\SXWI'/[I9U&X__]02P,$% @ *X1H56K30E]M
M @ @ < !$ !P9FUT+3(P,C(Q,3 X+GAS9,U576^;,!1]SZ_P>)X#)"$-
MJ$FEM:HT*=NDK%7[-AG[DE@%F]FF2?_]; >4DK9K(^UAON/>=^7W-^L:M*
M] A*
%Y7IP6M0A505$89*50^IK$*7=!Q'LP 18Q3/&P/7
M%G(%!6E*RV[$[X:4O.# ;.%+<*7M 9ZI#5%K,-])!;HF%#[L>C% R-6%5[54
M!HE7#;2%B=,T#7